Texas Instruments Incorporated (TXN) vs Vertex Pharmaceuticals Incorporated (VRTX): Which Is the Better Buy in 2026?
As of 2026-09-17, TXN is undervalued at $262, with a DCF intrinsic value of $365 and a margin of safety of 28%. VRTX is undervalued at $513, with an intrinsic value of $956 and a margin of safety of 46%. Of the two, VRTX has the wider margin of safety.
Rewards
- ★Texas Instruments Incorporated has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
- ★Return on equity has consistently exceeded 20% over 4 years, indicating efficient use of shareholder capital.
- ★PEG ratio of 0.94 suggests the stock is undervalued relative to its growth rate — paying less than 1x for each unit of earnings growth.
- ★Altman Z-Score of 12.04 indicates very low bankruptcy risk — the company is firmly in the safe zone.
- ★Net debt/EBITDA of -1.2x means the company holds more cash than debt — a net cash position.
Risks
- ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
- ⚠FCF yield of 1.5% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
- ⚠Trailing P/E of 39.9x is 47% above the historical average of 27.1x — the stock trades at a premium to its own history.
- ⚠FCF yield of 2.0% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
- ⚠Insiders have sold $2.3M worth of stock in the past 3 months — significant insider liquidation.
- ⚠Free cash flow has declined at a 6.6% CAGR over the past 4 years — a concerning trend.
Key Valuation Metrics
Learn more →Historical Fundamentals
Learn more →Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.
$1 Retained Earnings Test
Learn more →> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
Discounted Cash Flow (DCF) Analysis
Learn more →Reverse DCF — Market-Implied Growth
Learn more →What growth rate is the market pricing in at $262?
The market implies +20.0% Owner Earnings growth, above historical trends.
Standard FCF implies a demanding +24.8%, reflecting heavy growth investment.
What growth rate is the market pricing in at $513?
The market implies +13.9% Owner Earnings growth, above historical trends.
Standard FCF implies a demanding +19.4%, reflecting heavy growth investment.
Economic Moat Score
Learn more →Narrow moat with roic consistency as the key competitive advantage. Improving reinvestment efficiency would strengthen the moat.
Narrow moat with revenue predictability as the key competitive advantage. Improving margin stability would strengthen the moat.
Forensic Accounting
Learn more →M-Score Trend
Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
Ownership Breakdown
Learn more →High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.
Insider Buying Activity
Learn more →Open market purchases · includes direct & indirect ownership · excludes option exercises.
Insider Selling Activity
Learn more →Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.
🎭 Mr. Market's Mood
Learn more →"Market is pricing this stock without strong emotion in either direction"
"Market is pricing this stock without strong emotion in either direction"
Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
⚖️ Buffett Signal
Learn more →The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.
The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.
Frequently Asked Questions: TXN vs VRTX
Is Texas Instruments Incorporated or Vertex Pharmaceuticals Incorporated more undervalued in 2026?▼
Based on our discounted cash flow model, VRTX trades at a 46.3% margin of safety (intrinsic value $956 vs. price $513), compared to TXN's 28.2% margin of safety (intrinsic $365 vs. $262).
Which stock has a wider economic moat, Texas Instruments Incorporated or Vertex Pharmaceuticals Incorporated?▼
VRTX scores 65/100 (Narrow moat), while TXN scores 48/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.
Which company has better free cash flow, Texas Instruments Incorporated or Vertex Pharmaceuticals Incorporated?▼
Vertex Pharmaceuticals Incorporated (VRTX) generates a 2.0% free cash flow yield, compared to Texas Instruments Incorporated's 1.5%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.
Which stock has higher return on invested capital, Texas Instruments Incorporated or Vertex Pharmaceuticals Incorporated?▼
TXN earns 20.4% ROIC versus VRTX's 17.0%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.